Lista de obras - Jonathan G Pol - Dominio Público Uruguay

A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency

artículo científico publicado en 2020

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

scientific article published on 07 September 2019

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

scientific article published on 01 December 2019

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

artículo científico publicado en 2019

Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-α-stimulated signaling pathways and limits the extent of liver inflammation

artículo científico publicado en 2015

Anticancer effects of anti-CD47 immunotherapy in vivo

scientific article published on 11 December 2018

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

artículo científico publicado en 2017

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

artículo científico publicado en 2019

Autophagy induction for the treatment of cancer

artículo científico publicado en 2016

Autophagy-mediated metabolic effects of aspirin

artículo científico publicado en 2020

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

artículo científico publicado en 2016

Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy

artículo científico publicado en 2013

Consensus guidelines for the detection of immunogenic cell death

artículo científico publicado en 2014

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

artículo científico publicado en 2019

Customized Viral Immunotherapy for HPV-Associated Cancer

artículo científico publicado en 2017

Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responses

artículo científico publicado en 2013

Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination

artículo científico publicado en 2020

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy

artículo científico publicado en 2018

Effects of interleukin-2 in immunostimulation and immunosuppression

artículo científico publicado en 2020

Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning

scientific article published on 01 August 2020

Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease

artículo científico publicado en 2008

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin

artículo científico publicado en 2020

Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells

artículo científico publicado en 2016

First oncolytic virus approved for melanoma immunotherapy

artículo científico publicado en 2015

Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses

artículo científico publicado en 2013

Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models

artículo científico publicado en 2019

HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy

artículo científico publicado en 2013

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants

artículo científico publicado en 2018

Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies

Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy

artículo científico publicado en 2013

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

artículo científico publicado en 2017

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 30 July 2020

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts

scholarly article by Gautier Stoll et al published 2018 in OncoImmunology

Improved Swiss-rolling method for histological analyses of colon tissue

artículo científico publicado en 2022

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress

scientific article published on 23 April 2020

Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate

artículo científico publicado en 2019

Local anesthetics elicit immune-dependent anticancer effects

artículo científico publicado en 2022

Maraba virus as a potent oncolytic vaccine vector

scientific article published on 25 October 2013

Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)

artículo científico publicado en 2020

Metabolic effects of fasting on human and mouse blood in vivo

artículo científico publicado en 2017

Metabolic vulnerability of cisplatin-resistant cancers

scientific article published on 06 June 2018

Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccines

artículo científico publicado en 2013

Panorama from the oncolytic virotherapy summit

artículo científico publicado en 2013

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

article

Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination.

artículo científico publicado en 2016

Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring

artículo científico publicado en 2008

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 17 September 2020

S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3.

artículo científico publicado en 2016

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer

scientific article published on 20 July 2019

Trial Watch-Oncolytic viruses and cancer therapy

artículo científico publicado en 2015

Trial Watch: DNA vaccines for cancer therapy

artículo científico publicado en 2014

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

artículo científico publicado en 2015

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

artículo científico publicado en 2018

Trial Watch: Peptide-based anticancer vaccines

artículo científico publicado en 2015

Trial Watch: Radioimmunotherapy for oncological indications

artículo científico publicado en 2014

Trial Watch:: Oncolytic viruses for cancer therapy

artículo científico publicado en 2014

Trial watch: DNA-based vaccines for oncological indications

Trial watch: Dendritic cell-based anticancer therapy

artículo científico publicado en 2014

Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

artículo científico publicado en 2015

Trial watch: dietary interventions for cancer therapy

scholarly article by Sarah Lévesque et al published 2019 in OncoImmunology

Trial watch: peptide-based vaccines in anticancer therapy

artículo científico publicado en 2018

Tumor lysis with LTX-401 creates anticancer immunity

artículo científico publicado en 2019

Lista de obras de Jonathan G Pol

A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-α-stimulated signaling pathways and limits the extent of liver inflammation

Anticancer effects of anti-CD47 immunotherapy in vivo

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Autophagy induction for the treatment of cancer

Autophagy-mediated metabolic effects of aspirin

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy

Consensus guidelines for the detection of immunogenic cell death

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Customized Viral Immunotherapy for HPV-Associated Cancer

Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responses

Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy

Effects of interleukin-2 in immunostimulation and immunosuppression

Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning

Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin

Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells

First oncolytic virus approved for melanoma immunotherapy

Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses

Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models

HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants

Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies

Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts

Improved Swiss-rolling method for histological analyses of colon tissue

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress

Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate

Local anesthetics elicit immune-dependent anticancer effects

Maraba virus as a potent oncolytic vaccine vector

Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)

Metabolic effects of fasting on human and mouse blood in vivo

Metabolic vulnerability of cisplatin-resistant cancers

Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccines

Panorama from the oncolytic virotherapy summit

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination.

Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3.

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer

Trial Watch-Oncolytic viruses and cancer therapy

Trial Watch: DNA vaccines for cancer therapy

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

Trial Watch: Peptide-based anticancer vaccines

Trial Watch: Radioimmunotherapy for oncological indications

Trial Watch:: Oncolytic viruses for cancer therapy

Trial watch: DNA-based vaccines for oncological indications

Trial watch: Dendritic cell-based anticancer therapy

Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

Trial watch: dietary interventions for cancer therapy

Trial watch: peptide-based vaccines in anticancer therapy

Tumor lysis with LTX-401 creates anticancer immunity